Cargando…
In vitro Evaluation of Isoniazid Derivatives as Potential Agents Against Drug-Resistant Tuberculosis
The upsurge of multidrug-resistant tuberculosis has toughened the challenge to put an end to this epidemic by 2030. In 2020 the number of deaths attributed to tuberculosis increased as compared to 2019 and newly identified multidrug-resistant tuberculosis cases have been stably close to 3%. Such a c...
Autores principales: | Marquês, Joaquim Trigo, Frazão De Faria, Catarina, Reis, Marina, Machado, Diana, Santos, Susana, Santos, Maria da Soledade, Viveiros, Miguel, Martins, Filomena, De Almeida, Rodrigo F. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114799/ https://www.ncbi.nlm.nih.gov/pubmed/35600870 http://dx.doi.org/10.3389/fphar.2022.868545 |
Ejemplares similares
-
Contribution of Efflux to the Emergence of Isoniazid and Multidrug Resistance in Mycobacterium tuberculosis
por: Machado, Diana, et al.
Publicado: (2012) -
Effects of Dosage, Comorbidities, and Food on Isoniazid Pharmacokinetics in Peruvian Tuberculosis Patients
por: Requena-Méndez, Ana, et al.
Publicado: (2014) -
A Physiologically Based Pharmacokinetic Model of Isoniazid and Its Application in Individualizing Tuberculosis Chemotherapy
por: Cordes, Henrik, et al.
Publicado: (2016) -
Efflux Activity Differentially Modulates the Levels of Isoniazid and Rifampicin Resistance among Multidrug Resistant and Monoresistant Mycobacterium tuberculosis Strains
por: Machado, Diana, et al.
Publicado: (2018) -
HIV-1 Coinfection Does Not Reduce Exposure to Rifampin, Isoniazid, and Pyrazinamide in South African Tuberculosis Outpatients
por: Rockwood, Neesha, et al.
Publicado: (2016)